What is the recommended treatment for urinary tract infections (UTIs) in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for UTIs in Men

For urinary tract infections in men, the recommended treatment is a 7-14 day course of antibiotics, with first-line options including trimethoprim-sulfamethoxazole (TMP-SMX), nitrofurantoin, or fluoroquinolones based on local resistance patterns. 1

Diagnostic Approach

  • Obtain urinalysis and urine culture before starting antibiotics
  • Culture confirmation is essential for tailoring therapy based on bacterial sensitivities
  • Treatment may be started empirically while awaiting culture results

Antibiotic Selection for Men with UTIs

First-Line Options

  • Trimethoprim-sulfamethoxazole (TMP-SMX): 160/800 mg twice daily for 7-14 days
    • Use only if local resistance is <20%
    • Avoid in patients with sulfa allergies
  • Nitrofurantoin: 100 mg twice daily for 7 days
    • Contraindicated if CrCl <30 mL/min
    • Highly effective against E. coli (which causes >75% of UTIs)
  • Fluoroquinolones (e.g., levofloxacin): While generally reserved as second-line, may be appropriate first-line in men due to concerns about prostate involvement 1, 2
    • Levofloxacin 250-500 mg once daily for 7-14 days
    • Good penetration into prostatic tissue

Alternative Options

  • Cephalexin: 500 mg four times daily for 7 days
  • Amoxicillin-clavulanate: Based on susceptibility testing
  • Fosfomycin: 3 g single dose, may require multiple doses for men

Important Considerations for Men with UTIs

Treatment Duration

  • Men typically require longer treatment courses (7-14 days) than women with uncomplicated UTIs 1, 2
  • This extended duration is due to the higher likelihood of complicated infection and potential prostatic involvement

Special Considerations

  • Prostate Involvement: UTIs in men often involve the prostate, requiring antibiotics with good prostatic penetration 2

    • Fluoroquinolones achieve good prostatic concentrations
    • For bacterial prostatitis, treatment duration may extend to 14-42 days 3
  • Renal Function: Adjust dosing based on creatinine clearance 1

    • For levofloxacin:
      • CrCl ≥50 mL/min: 500 mg once daily
      • CrCl 26-49 mL/min: 500 mg once daily
      • CrCl 10-25 mL/min: 250 mg once daily
  • Recurrent UTIs: Consider urologic evaluation to identify underlying structural abnormalities

Antibiotic Resistance Considerations

  • Local antibiogram patterns should guide empiric therapy 1, 4
  • Increasing resistance to TMP-SMX and aminopenicillins has been observed 2, 4
  • Fluoroquinolones generally maintain good activity against uropathogens but should be used judiciously due to resistance concerns 4

Follow-up

  • Monitor for symptom resolution within 48-72 hours
  • If symptoms persist, reassess with repeat culture and consider urologic evaluation
  • Consider imaging studies if recurrent infections or concern for anatomic abnormalities

Common Pitfalls

  • Undertreating: Men require longer treatment courses than women with uncomplicated UTIs
  • Missing prostatitis: Consider prostate involvement in all men with UTIs
  • Ignoring resistance patterns: Local antibiograms should guide empiric therapy
  • Inadequate follow-up: Men with UTIs may require urologic evaluation, especially with recurrent infections

References

Guideline

Uncomplicated Urinary Tract Infections (UTIs) Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Role of levofloxacin in the treatment of urinary tract infections].

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.